Search Results - "Garib, Shan Ashton"

Budget Impact Of Eltrombopag As First-Line Treatment For Severe Aplastic Anemia In The United States by Tremblay, Gabriel, Said, Qayyim, Roy, Anuja Nidumolu, Cai, Beilei, Ashton Garib, Shan, Hearnden, Jaclyn, Forsythe, Anna

“…Severe aplastic anemia (SAA) is a rare autoimmune condition resulting in low blood cell counts across lineages. Immunosuppressive therapy (IST) has…”
Get full text

Unresectable hepatocellular carcinoma treated with lenvatinib or sorafenib: A disease modeling study by Tremblay, Gabriel, Copher, Ronda, Garib, Shan Ashton, Pan, Janice

“…Abstract only…”
Get full text

Younger Patients Are Impacted By Post-Transplant Lymphoproliferative Disorder: Findings from a Systematic Literature Review of Real-World Evidence by Watson, Crystal, Xu, Hairong, Forsythe, Anna, Garib, Shan Ashton, Barlev, Arie

“…Introduction: Transplant recipients younger than 18 years old are believed to have a 2- to 4-fold higher risk of developing post-transplant lymphoproliferative…”
Get full text

Treatment Patterns for Patients with Post-Transplant Lymphoproliferative Disorder Who Fail Rituximab after Allogeneic Hematopoietic Stem Cell Transplantation: Findings from a Systematic Literature Review by Xu, Hairong, Watson, Crystal, Garib, Shan Ashton, Forsythe, Anna, Barlev, Arie

“…Introduction: Post-transplant lymphoproliferative disorder (PTLD) is a well-recognized disease after allogeneic hematopoietic stem cell transplantation (HCT)…”
Get full text

Comparing Costs and Consequences of Eltrombopag Plus IST Versus IST Alone for First-Line Treatment in Severe Aplastic Anemia: Results from a Responder Analysis by Tremblay, Gabriel, Said, Qayyim, Cai, Beilei, Garib, Shan Ashton, Tomaras, Dimitrios, Forsythe, Anna, Roy, Anuja

“…Background: Severe Aplastic Anemia (SAA) is a rare bone marrow disorder characterized by inadequate levels of peripheral, multi-lineage blood cells. Of the two…”
Get full text

Cost-Effectiveness of Dolutegravir as a First-Line Treatment Option in the HIV-1–Infected Treatment-Naive Patients in Russia by Tremblay, Gabriel, Chounta, Vasiliki, Piercy, James, Holbrook, Tim, Garib, Shan Ashton, Bukin, Evgeny K., Punekar, Yogesh Suresh

“…To evaluate the cost effectiveness of dolutegravir + abacavir/lamivudine (DTG + ABC/3TC) compared with raltegravir + abacavir/lamivudine (RAL + ABC/3TC) and…”
Get full text